Advanced therapy medicinal products
33 results
Applied filters
Ex-vivo non-GMO gene therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmacy expertise prior to an organisation implementing ex-vivo non-genetically modified organism gene therapies.
Marketed CAR-T therapy
13 February 2026This document outlines key areas where Chief Pharmacists should focus pharmaceutical expertise prior to an organisation implementing CAR-T therapy.
Somatic cell therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmaceutical expertise prior to an organisation implementing somatic cell therapy product.
In-vivo non-GMO gene therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmacy expertise prior to an organisation implementing in-vivo non-genetically modified organism gene therapies.
Handling dry ice and vapour phase nitrogen shippers
11 February 2026Practical advice, training and competency assessments for pharmacy departments receiving shipments and storing medicines at ultra-low temperatures.
Supportive medicines guidance for adults on CAR-T cell therapy
11 February 2026This document provides expert clinical pharmacy guidance on supportive medicines in order to facilitate the treatment of complex CAR-T Cell Therapy patients.
Costing clinical trials of ATIMPs using the NIHR iCT
11 February 2026Guidance to support and promote consistent pharmacy costing for commercial clinical trials involving ATIMPs.
Requirements for governance and preparation of gene therapy
11 February 2026Practical advice for centres implementing gene therapies detailing governance requirements and optimal preparation location decision making support.
Outsourcing ATIMP storage or preparation across legal boundaries
11 February 2026Guidance on the considerations for pharmacy clinical trial sites outsourcing activities involved in the delivery of ATIMPs.
Outsourcing marketed ATMPs: A template technical agreement
11 February 2026A template Quality Technical Agreement for outsourcing the receipt, storage, preparation and onward supply of marketed cryopreserved ATMPs.